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Rebalancing the global battle against tuberculosis
Meetings of health ministers from the ﬁ ve BRICS 
countries (Brazil, Russia, India, China, and South Africa) 
have produced two joint statements in less than a year: 
the Delhi Communiqué1 (Jan 12, 2013) and the Cape 
Town Communiqué2 (Nov 7, 2013). Both statements 
bode well for global tuberculosis control. The Delhi 
Communiqué underscores the principle of equity and 
focuses on populations who are most aﬀ ected by the 
disease. The Cape Town Communiqué emphasises 
promotion of consortia of researchers to collaborate 
for clinical trials of drugs and vaccines, strengthening 
of access to aﬀ ordable, high-quality, eﬀ ective, and safe 
medicines, and delivery of high-quality health care. 
These approaches are in agreement with the overall 
approach of tuberculosis elimination strategies, which 
foster innovation within well managed systems and 
through bold policies (eg, for infection control, rational 
drug use, and mandatory case notiﬁ cation).3 
With decreases in incidence and mortality, progress in 
tuberculosis control has been evident.4 However, several 
challenges persist, including tackling of multidrug-
resistant tuberculosis (which has emerged because of 
widespread access and use of tuberculosis drugs over 
the past decades), and replacement of old, inadequate 
methods for diagnosis, treatment, and prevention with 
new, rapid methods. Changes in the global political 
economy also call for adjustments to ﬁ nancing of global 
tuberculosis control. Half of the high-tuberculosis-
incidence countries that were classiﬁ ed as low income in 
2000 are now in the middle-income category, and more 
are expected to join this group by 2020 (ﬁ gure). The 
ﬁ ve BRICS countries, which account for 25% of global 
gross domestic product, 30% of global land area, and 
45% of the world’s population, also bear about 45% of 
the world’s burden of tuberculosis and more than 60% 
of the burden of multidrug-resistant tuberculosis.4,5 
This ﬁ nding is not surprising; four-ﬁ fths of people who 
survive on less than US$2 a day are estimated to live in 
middle-income countries.6 BRICS and other middle-
income countries with a large burden of tuberculosis 
should also have the resources to tackle the disease. The 
global response to tuberculosis needs to be rebalanced.
In view of the present and future requirements of 
global tuberculosis control, a sustained ﬁ ght against 
tuberculosis now needs enhanced investments on 
at least three fronts. First, continued international 
ﬁ nancing is necessary to further support the lowest-
income countries in sub-Saharan Africa and elsewhere 
with necessary resources and technical assistance;7 a 
handful of fragile states need special attention and 
full support. Second, the BRICS and other middle-
income countries should continue to enhance domestic 
health investments, while beneﬁ ting from nuanced 
international ﬁ nancing during a transition period 
towards full self-reliance in tuberculosis care and 
prevention. Third, far larger investments (including 
from BRICS countries) are needed to boost research, 
development, and introduction of new drugs, 
diagnostics, and vaccines, without which tuberculosis 
elimination cannot be achieved.8
The two statements from the BRICS partnership could 
help to inform how best emerging economies can 
contribute to achievement of ambitious global targets 
for tuberculosis control. BRICS and other economies in 
transition have a great responsibility and the potential 
to contribute to all aspects of care, prevention, and 
research for tuberculosis. Middle-income countries 
will need to enhance investments in social protection, 
including universal health coverage, to ensure prompt 
diagnosis of tuberculosis and completion of treatment. 
As the economies of these countries further improve, 
more countries will join this front, leaving fewer in need 
of substantial external assistance (ﬁ gure). Countries 
of the Organisation for Economic Co-operation and 
Figure: Most tuberculosis cases will be in middle-income and high-income 
countries by 2020
Figure based on data from WHO, UNDP, and the World Bank.
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Development and international ﬁ nancing mechanisms 
(eg, the Global Fund to ﬁ ght AIDS, Tuberculosis, and 
Malaria) should coordinate their eﬀ orts and adjust aid 
ﬂ ows towards the lowest-income countries and fragile 
states while leveraging domestic resources in the BRICS 
and other emerging economies to address equity and 
support vulnerable populations in the lowest-income 
quintile.
In the new era of a globalised world and growing 
importance of global public goods, the economic 
transition in health calls for rebalancing of health 
development aid, international cooperation, and 
scientiﬁ c leadership. Collective, coordinated, and 
country-led responses for a healthier world are the 
appropriate and responsible way forward. In this 
endeavour, the importance of country ownership with 
local advocacy and capacity, and international technical 
assistance and cooperation, cannot be overstressed.
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